Inhibition of H-ras oncogene transformation of NIH3T3 cells by protease inhibitors.
The protease inhibitors antipain, leupeptin, alpha 1-antitrypsin, and epsilon-aminocaproic acid were found to inhibit transformation of NIH3T3 cells after transfection with an activated H-ras oncogene. Inhibition of focus formation by protease inhibitors was concentration dependent and maximal at 50% of control values. Transfection of a gene for neomycin resistance was not affected by protease inhibitors. Antipain was inactive if present only during the first 2 days of the gene transfer protocol or only during the final 10 days of the experiment. However, the full effect was observed when antipain was added at the subculture step on day 3 and during the subsequent cell proliferation. If cells were not subcultured, the yield of the foci per microgram of DNA was sharply reduced and addition of antipain did not further suppress the transformation rate. Subculture of NIH3T3 cells 3 days after transfection at lower cell densities resulted in higher transformation efficiency. The results suggest that transformation of NIH3T3 cells by a single mutated oncogene may involve multiple stages including cell proliferation and that part of this process is susceptible to inhibition by protease inhibitors.
D015119:Aminocaproic Acid / Q000494:pharmacology; D000818:Animals; D000976:Antipain / Q000494:pharmacology; D002455:Cell Division; D002460:Cell Line; D004351:Drug Resistance; D007976:Leupeptins / Q000494:pharmacology; D009355:Neomycin / Q000494:pharmacology; D009857:Oncogenes; D010957:Plasmids; D011480:Protease Inhibitors / Q000494:pharmacology*; D014162:Transfection; D000515:alpha 1-Antitrypsin / Q000494:pharmacology
D007976:Leupeptins; D011480:Protease Inhibitors; D000515:alpha 1-Antitrypsin; D000976:Antipain; D009355:Neomycin; C032854:leupeptin; D015119:Aminocaproic Acid